In a new job - September 19, 2022
Nordic Nanovector consolidates its Board
Three members of the company’s Board, Solveig Hellebust, Jean Pierre Bizzari and Thomas Ramdahl, has decided to step down from the Board with immediate effect. Following the decisions to discontinue the PARADIGME study for Betalutin, restructure the company and appoint Carnegie Investment Bank to explore strategic options, the three members have taken this decision. Read […]
In a new job - September 15, 2022
She is the new Interim Director General of SwedenBIO
Frida Lawenius, who has been Deputy Director General of SwedenBIO since January 2020, brings experience from both political influence and strategic development into her new role. ”Frida Lawenius is an experienced leader who is well driven in the life science industry’s needs and in the daily operations of SwedenBIO’s office. She also has cultivated well-functioning […]
In a new job - September 1, 2022
He is the new Director of HiLIFE
The rector of the University of Helsinki has appointed Professor Jari Koistinaho as director of the Helsinki Institute of Life Science (HiLIFE). “The life science disciplines are developing globally in leaps and bounds, thanks to new knowledge and the latest technologies,” notes Koistinaho. “Breakthroughs in life science will change our view of ourselves as humans […]
In a new job - August 26, 2022
The CEO of InDex Pharmaceuticals steps down
InDex Pharmaceuticals Holding announced in April 2022 that after more than seven years as CEO, Peter Zerhouni has decided to leave his position. The company’s CFO Johan Giléus has been appointed acting CEO while a new CEO is being recruited, and he will also continue as CFO. “With the drug candidate cobitolimod in phase III, […]
In a new job - August 17, 2022
Idogen to convene major owners for election to Board
Idogen has announced that an Extraordinary General Shareholder Meeting will be convened to propose the election of two new members to the Board of Directors: Joakim Söderström and Niklas Wallett, representing a consortium that owns approximately 17% of the votes. The election of Joakim Söderström as new Chairman of the Board has also been proposed. […]
In a new job - August 16, 2022
Anders Blanck leaves his position as CEO of Lif
Anders Blanck has been CEO of the trade association for the research-based pharmaceutical industry in Sweden (Lif) since 2011, and before that he was deputy CEO since 2005. Blanck will continue as CEO this fall in order to give the Board time to find a successor. “I am both very grateful and proud of what […]
